[1] Ahmed MG, Shaheen N, Shaheen A, et al. Outcomes of endovascular treatment alone or with intravenous alteplase in acute ischemic stroke patients: a retrospective cohort study[J]. Brain Hemorrhages, 2024,5(1): 21-28.
[2] Li SD, Wang AX, Shi L, et al. Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): a randomized double-blind placebo-controlled pilot clinical trial[J]. Chin Med J (Engl), 2025,138(5):579-588.
[3] Czap AL, Sheth SA. Overview of imaging modalities in stroke[J]. Neurology, 2021, 97(20 Suppl 2):S42-S51.
[4] Simpkins AN, Janowski M, Oz HS, et al. Biomarker application for precision medicine in stroke[J]. Transl Stroke Res, 2020,11(4): 615-627.
[5] Dong J, Zeng Z, Huang Y, et al. Challenges and opportunities for circRNA identification and delivery[J]. Crit Rev Biochem Mol Biol, 2023, 58(1): 19-35.
[6] Xu F, Xiao Q, Du WW, et al. CircRNA: functions, applications and prospects[J]. Biomolecules, 2024,14(12):1503.
[7] Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins[J]. Mol Cancer, 2020,19(1): 172.
[8] Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J]. Mol Cancer, 2017,16(1):94.
[9] Enuka Y, Mattia L, Morris EF, et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor[J]. Nucleic Acids Res, 2016, 44(3): 1370-1383.
[10] Chen XL,Tan QD, Chen KJ, et al.CircRNA and stroke: new insight of potential biomarkers and therapeutic targets[J]. Neurochem Res, 2024, 49(3): 557-567.
[11] Gu T, Tan QD, Chen KJ, et al.The impact of centrifugal force on isolation of bone marrow mononuclear cells using density gradient centrifugation[J]. Aesthetic Plast Surg, 2024,48(9): 1855-1866.
[12]Çorbacıoɡ̆lu ŞK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value[J]. Turk J Emerg Med, 2023, 23(4): 195-198.
[13] Liu X., Yu Z, Shurong Z, et al. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines[J]. J Control Release, 2022, 348: 84-94.
[14] Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs[J]. Cell Death Differ, 2022, 29(3): 481-491.
[15] Xu Z, Yang F, Zheng L.Uncovering the dual roles of peripheral immune cells and their connections to brain cells in stroke and post-stroke stages through single-cell sequencing[J]. Front Neurosci, 2024, 18:1443438.
[16] Mohammad TAM, Al-Haideri M, Al-Naqshabandi AA.Decoding the immune response: analyzing PBMCs in ischemic stroke and evaluating the effects of Rivaroxaban on gene expression[J]. Hum Immunol, 2025, 86(2):111252.
[17] Otsu Y, Hatakeyama M, Kanayama T, et al.Oxygen-glucose deprived peripheral blood mononuclear cells protect against ischemic stroke[J]. Neurotherapeutics, 2023, 20(5): 1369-1387.
[18] Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms[J]. CNS Neurosci Ther, 2021, 27(1): 36-47.
[19] Zu J, Zuo L, Zhang Z, et al. Circular RNA FUNDC1 for prediction of acute phase outcome and long-term survival of acute ischemic stroke[J]. Front Neurol, 2022, 13: 846198.
[20] Liu Y, Li Y, Zang J, et al. CircOGDH is a penumbra biomarker and therapeutic target in acute ischemic stroke[J]. Circ Res, 2022, 130(6): 907-924.
[21] Zuo L, Zhang L, Zu J, et al. Circulating circular RNAs as biomarkers for the diagnosis and prediction of outcomes in acute ischemic stroke[J]. Stroke, 2020, 51(1): 319-323.
[22] Lu Y, Huang J, Ying X, et al. RING finger 138 deregulation distorts NF-кB signaling and facilities colitis switch to aggressive malignancy[J]. Signal Transduct Target Ther, 2022, 7(1): 185.
[23] Locke AJ, Farraj RA, Tran C, et al. The role of RNF138 in DNA end resection is regulated by ubiquitylation and CDK phosphorylation[J]. J Biol Chem, 2024, 300(3): 105709.
[24] Halim DO, Krishnan G, Hass EP, et al. The exocyst subunit EXOC2 regulates the toxicity of expanded GGGGCC repeats in C9ORF72-ALS/FTD[J]. Cell Rep, 2024,43(7): 114375.
[25] Van Bergen NJ, Ahmed SM, Collins F, et al. Mutations in the exocyst component EXOC2 cause severe defects in human brain development[J]. J Exp Med, 2020,217(10):e20192040.